The use of sodium-glucose cotransporter type 2 inhibitors for the purpose of treating the chronic cardiac failure in oncology patients receiving cardiotoxic chemotherapy: preliminary results
BACKGROUND: Chronic cardiac failure belongs to the most threatening and delayed manifestations of cardiotoxicity in oncology patients receiving the treatment with antitumor medicines. As of today, only two groups of drugs were proven to have significant cardioprotective effects in these categories o...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Eco-vector
2024-11-01
|
| Serie: | Клиническая практика |
| Soggetti: | |
| Accesso online: | https://journals.eco-vector.com/clinpractice/article/viewFile/629938/pdf |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|